Danaher Corp. (DHR)$172.00
Research Snapshot
Static fundamentals, valuation context, and investor signals for Danaher Corp. (DHR).
Valuation
29.5x
EV/FCF, 3.4% FCF yield
Quality
5.1%
ROIC, 21.4% FCF margin
Growth
2.0%
5Y sales (revenue) CAGR
Balance sheet
0.4x
Debt/equity, 1.9x current ratio
Superinvestors
10
Top: Pat Dorsey (8.8%)
Strengths to research
- Free cash flow margin is healthy at 21.4%.
- Debt/equity looks manageable at 0.4x.
- 10 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Quality Scorecard
Build-time composite score for DHR.
Peer Comparison
Target stock against 8 market-cap comparable peers.
| DHR Target | Danaher Corp. | $141.3B | 34.1x | 29.5x | 5.1% | 2.0% | 21.4% | 59.1% | 2.5x | N/A |
| TMO | Thermo Fisher Scientific | $159.4B | 25.3x | 30.0x | 7.3% | 6.7% | 14.1% | N/A | 3.3x | N/A |
| LZAGY | Lonza Group Ag Unspon ADR | $52.5B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| IDXX | IDEXX Laboratories | $38.2B | 42.8x | 36.4x | 51.5% | 9.7% | 24.6% | 61.8% | 0.2x | N/A |
| A | Agilent Technologies | $30.9B | 25.2x | 27.9x | 13.3% | 5.4% | 16.6% | N/A | 0.7x | N/A |
| IQV | IQVIA Holdings Inc. | $26.9B | 21.4x | 12.1x | 20.9% | 7.5% | 12.6% | N/A | -0.6x | N/A |
| MTD | Mettler-Toledo International Inc. | $22.7B | 26.2x | 29.2x | 42.1% | 5.5% | 21.1% | 59.4% | N/A | N/A |
| NTRA | Natera Inc. | $21.4B | -133.7x | 186.2x | -12.2% | 42.6% | 4.7% | N/A | N/A | N/A |
| LH | Labcorp Holdings Inc. | $20.7B | 24.8x | 16.7x | 10.2% | -0.0% | 8.6% | 28.8% | -0.3x | N/A |
Financial Charts
No financial data available for DHR (annual).
10 superinvestors own DHR
Current quarter ownership and quarter-over-quarter share changes.
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 819,679 | $155M | 1.81% | 0.0% |
| Pat Dorsey Dorsey Asset Management | 580,240 | $110M | 8.76% | ▲ +104.5% |
| Daniel Loeb Third Point | 525,000 | $100M | 4.78% | New |
| Wallace Weitz Weitz Large Cap Equity Fund | 477,750 | $91M | 6.32% | 0.0% |
| Bill & Melinda Gates Foundation Trust Bill & Melinda Gates Foundation Trust | 373,000 | $71M | 0.22% | 0.0% |
| Dodge & Cox Dodge & Cox | 16,450 | $3M | 0.00% | 0.0% |
| Torray Funds Torray Funds | 1,871 | $355,000 | 0.06% | 0.0% |
| Bill Nygren Oakmark Select Fund | 1,838 | $348,000 | 0.00% | 0.0% |
| David Katz Matrix Asset Advisors | 1,693 | $321,000 | 0.03% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 1,135 | $215,000 | 0.00% | 0.0% |